Our Futures and Innovation room is about learning and change.
We help organizations and ideas be fit for purpose, connected with and influencing ecosystems in an evolving world. This may be via a look back, to learn from experience, or a look forward, to vision and strategize new opportunities. Or a scaling of a new solution that can drive impact and positive change. We specialize in mission driven organizations and ideas iin the public and private sectors.
For humanity.
vision
strategy
systems thinking
culture
Recent project
WHO: Preventing market failure of the world’s first malaria vaccine through innovative financing
The world’s first malaria vaccine received a positive scientific opinion from the European Medicines Authority in 2015. However, before being recommended for roll-out in Africa, experts wanted a deeper understanding of the vaccine’s safety and implementation complexity, and the vaccine manufacturer needed financial support in order to keep manufacturing lines warm during continued studies. The Yellow House supported WHO and its partners in identifying innovative financing options and deal terms for the working capital needed by the manufacturer. A financing mechanism was put in place in 2021 that is now facilitating a smooth transition to broad roll-out.
Recent project
WHO: Assessment of the UN Covid-19 Supply Chain System
We performed an outside-in assessment of the United Nations’ COVID-19 Supply Chain System setup, performance, and activities to date. Leveraging a steering group, the output of a stakeholder survey and interviews, and combined with a review of key operational processes, organisational roles and responsibilities, and technology systems, the project worked to measure performance and provide insights and recommendations for improvements. TYH was pleased to partner with MMGH on the assessment.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Equitable access to essential medical products, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, and their scientifically sound and cost-effective use is one of the six health systems building blocks. To support countries to build their health systems to achieve universal health coverage (UHC) through a primary health care (PHC) approach, we designed the scope, structure, functions, and ways of working so that WHO’s ‘access to essential medicines’ is fully integrated in UHC and PHC.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Equitable access to essential medical products, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, and their scientifically sound and cost-effective use is one of the six health systems building blocks. To support countries to build their health systems to achieve universal health coverage (UHC) through a primary health care (PHC) approach, we designed the scope, structure, functions, and ways of working so that WHO’s ‘access to essential medicines’ is fully integrated in UHC and PHC.
Access to Health Products - a key building block of universal health coverage Client: WHO (UHC/LC)
Equitable access to essential medical products, vaccines and technologies of assured quality, safety, efficacy and cost-effectiveness, and their scientifically sound and cost-effective use is one of the six health systems building blocks. To support countries to build their health systems to achieve universal health coverage (UHC) through a primary health care (PHC) approach, we designed the scope, structure, functions, and ways of working so that WHO’s ‘access to essential medicines’ is fully integrated in UHC and PHC.
Recent project
IDB: Governance framework options for regional vaccine production in South America (PROSUR)
The Yellow House supported FIND’s shift to a global alliance with CEO-level thought-partnership on the development of its new strategy including the what, the how, principles, and enablers. The focus was on optimizing diagnostic procurement and supply chains and landscaping the diagnostics ecosystem. The result was a shift from a primarily upstream focused work to an end-to-end approach -- from R&D of novel diagnostics to their use at primary health care centers.
Recent project
WIPO: Intellectual property (IP) – understanding how it enabled and/or inhibited access to Covid-19 vaccines
WIPO commissioned a study on whether IP contributed to or inhibited Covid-19 vaccines success. TYH was a thought-partner throughout the study and provided expert commentary to supplement the report.
Recent project
Inter-American Development Bank: REGIONAL VACCINE PRODUCTION
Expansion of vaccine production in PROSUR countries to improve access during pandemics and routine vaccine needs The Yellow House worked with IDB and PROSUR to develop governance options for the expansion of capacity and vaccine production for consideration by the eight PROSUR countries (Argentina, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay and Peru).
Related research and thought leadership
Our latest thought pieces on futures and innovation
.jpeg)
